Woman, 23, diagnosed with brain tumour despite not having any of the typical symptoms and just feeling off
Edina Szilveszter, from Warrington, had spoken to friends about feeling something wasn t quite right within her head but says she had none of the symtpoms often associated with a brain tumour
Olivia Williams
Don t miss a thing by getting the latest from the Manchester Evening News sent
direct to your inboxInvalid EmailSomething went wrong, please try again later.
Click here
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Testicular cancer symptoms: how to examine
gq-magazine.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gq-magazine.co.uk Daily Mail and Mail on Sunday newspapers.
Woman with lung cancer urges others to recognise early signs
wirralglobe.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wirralglobe.co.uk Daily Mail and Mail on Sunday newspapers.
PEOPLE in South Cumbria and Lancashire are being urged to be alert to the warning signs and symptoms of ovarian cancer. Every year in the UK, 7,300 women are diagnosed with ovarian cancer – that’s 20 per day. A 2020 report from North West Cancer Research found that in Lancashire, ovarian cancer is 10 per cent higher than the national average. Ovarian cancer is one of the most common types of cancer in women. It mainly affects women who have been through the menopause, but it can affect women of all ages. Urging people to speak to their GP if they have any of the signs of symptoms of ovarian cancer, Dr Neil Smith, local GP and primary care director for Lancashire and South Cumbria Cancer Alliance, said: “Your GP can assess you and perhaps run some simple tests to better understand your symptoms.
Blood test picks out prostate cancer drug resistance 04
Blood test picks out prostate cancer drug resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
The new research paves the way for information from a blood test to inform prostate cancer treatment in future, with only those patients whose cancers are free of resistance mutations taking the drug, abiraterone.
The study is also a proof of principle that tests for cancer DNA in the bloodstream can be used to detect drug resistance mutations – allowing patients who will not benefit from one drug to be given an alternative treatment instead.